Redeye: Stille - Another leap forward
Redeye adjusts its estimates and valuation following the SEK425m directed share issue and the acquisition of Fehling Instruments, which we believe will pave the way for margin expansion for Stille.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/